Can flashing lights stall Alzheimer's? What the science shows
Immersive audiovisual experiences may help combat Alzheimer's symptoms, showing promise in stabilizing cognitive decline in patients.
Can I survive for 24 hours without GPS navigation?
Taxi and ambulance drivers are less likely to die from Alzheimer's due to required navigation skills, despite lower life expectancy.
4 science-backed habits to stay mentally sharp into your 70s
Exercise plays a crucial role in maintaining cognitive health and preventing cognitive decline as one ages.
Memory Loss Isn't the Only Sign of Dementia
Financial mismanagement can signal early brain changes related to dementia, particularly in frontotemporal dementia patients who exhibit altered judgment.
Sexism could put women at higher risk of Alzheimer's and dementia, says study
Women born in sexist U.S. states experience faster memory decline, with a significant 9-year difference compared to those from less sexist states.
Can flashing lights stall Alzheimer's? What the science shows
Immersive audiovisual experiences may help combat Alzheimer's symptoms, showing promise in stabilizing cognitive decline in patients.
Can I survive for 24 hours without GPS navigation?
Taxi and ambulance drivers are less likely to die from Alzheimer's due to required navigation skills, despite lower life expectancy.
4 science-backed habits to stay mentally sharp into your 70s
Exercise plays a crucial role in maintaining cognitive health and preventing cognitive decline as one ages.
Memory Loss Isn't the Only Sign of Dementia
Financial mismanagement can signal early brain changes related to dementia, particularly in frontotemporal dementia patients who exhibit altered judgment.
Sexism could put women at higher risk of Alzheimer's and dementia, says study
Women born in sexist U.S. states experience faster memory decline, with a significant 9-year difference compared to those from less sexist states.
Blood tests could soon predict your risk of Alzheimer's
Blood test for Alzheimer's risk could soon be as simple as testing cholesterol levels.
Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
The regulatory approval path for simufilam is fraught with controversy and allegations of research misconduct.
Which disease-modifying Alzheimer's drugs are the most promising?
The UK health watchdog has rejected two new Alzheimer's drugs due to concerns over their effectiveness and potential side effects.
Grasping for hope: The heartbreaking journey through Alzheimer's drug trials
John's emotional journey with Cheryl highlights the complexity of caring for a loved one with Alzheimer's and the search for effective treatments.
Francisco Lopera obituary: neurologist who traced genetic origin of early-onset Alzheimer's
Francisco Lopera's family-centered approach transformed Alzheimer's research, enhancing understanding of the disease's genetics and fostering trust in clinical settings.
Trial of Controversial Alzheimer's Drug Halted After Disappointing Results
Cassava Sciences halted the advanced trial for simufilam as it failed to reduce cognitive decline in Alzheimer's patients, disappointing many.
Blood tests could soon predict your risk of Alzheimer's
Blood test for Alzheimer's risk could soon be as simple as testing cholesterol levels.
Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
The regulatory approval path for simufilam is fraught with controversy and allegations of research misconduct.
Which disease-modifying Alzheimer's drugs are the most promising?
The UK health watchdog has rejected two new Alzheimer's drugs due to concerns over their effectiveness and potential side effects.
Grasping for hope: The heartbreaking journey through Alzheimer's drug trials
John's emotional journey with Cheryl highlights the complexity of caring for a loved one with Alzheimer's and the search for effective treatments.
Francisco Lopera obituary: neurologist who traced genetic origin of early-onset Alzheimer's
Francisco Lopera's family-centered approach transformed Alzheimer's research, enhancing understanding of the disease's genetics and fostering trust in clinical settings.
Trial of Controversial Alzheimer's Drug Halted After Disappointing Results
Cassava Sciences halted the advanced trial for simufilam as it failed to reduce cognitive decline in Alzheimer's patients, disappointing many.
Monitoring ARIA in Anti-Amyloid Therapy in Alzheimer's
Advancements in Alzheimer's treatment focus on early intervention via antiamyloid-beta monoclonal antibodies to target disease causes rather than just symptoms.
Controversial New Guidelines Would Diagnose Alzheimer's Before Symptoms Appear
Early detection of Alzheimer's disease is crucial for effective treatment and management.
Study says scientists may be able to 'listen' for Alzheimer's disease
Detection of Alzheimer's may be more effective through auditory analysis rather than eye movement, using an innovative device to track eardrum vibrations.
Monitoring ARIA in Anti-Amyloid Therapy in Alzheimer's
Advancements in Alzheimer's treatment focus on early intervention via antiamyloid-beta monoclonal antibodies to target disease causes rather than just symptoms.
Controversial New Guidelines Would Diagnose Alzheimer's Before Symptoms Appear
Early detection of Alzheimer's disease is crucial for effective treatment and management.
Study says scientists may be able to 'listen' for Alzheimer's disease
Detection of Alzheimer's may be more effective through auditory analysis rather than eye movement, using an innovative device to track eardrum vibrations.
Alzheimer's timeline shows changes start as trickle, become torrent
Alzheimer's disease has two distinct phases, indicating a slow onset followed by rapid deterioration, with vulnerable neurons identified for potential early treatment.
Non-Neuron Brain Cells Produce a Third of Amyloid Plaque in Alzheimer's Disease - News Center
Oligodendrocytes contribute to about one-third of amyloid plaque formation in Alzheimer's disease, challenging previous understanding and informing new therapies.
This metabolic brain boost revives memory in Alzheimer's mice
An experimental cancer drug has shown promise in re-energizing the brains of Alzheimer's mice, indicating potential new treatment methods.
One day, we may all have brain chips to help remember where our keys are: scientists
Kahana's research shows potential for brain stimulation to significantly improve memory recall.
Cellular communities reveal trajectories of brain ageing and Alzheimer's disease - Nature
The study presents a new understanding of Alzheimer's disease by identifying unique cellular trajectories and populations linked to its onset.
Microplastics found in human brains could be behind rising Alzheimer's
Microplastics found in human brains may be linked to rising Alzheimer's cases, necessitating further research.
Alzheimer's timeline shows changes start as trickle, become torrent
Alzheimer's disease has two distinct phases, indicating a slow onset followed by rapid deterioration, with vulnerable neurons identified for potential early treatment.
Non-Neuron Brain Cells Produce a Third of Amyloid Plaque in Alzheimer's Disease - News Center
Oligodendrocytes contribute to about one-third of amyloid plaque formation in Alzheimer's disease, challenging previous understanding and informing new therapies.
This metabolic brain boost revives memory in Alzheimer's mice
An experimental cancer drug has shown promise in re-energizing the brains of Alzheimer's mice, indicating potential new treatment methods.
One day, we may all have brain chips to help remember where our keys are: scientists
Kahana's research shows potential for brain stimulation to significantly improve memory recall.
Cellular communities reveal trajectories of brain ageing and Alzheimer's disease - Nature
The study presents a new understanding of Alzheimer's disease by identifying unique cellular trajectories and populations linked to its onset.
Microplastics found in human brains could be behind rising Alzheimer's
Microplastics found in human brains may be linked to rising Alzheimer's cases, necessitating further research.
AlzPath's blood test for ptau217 offers early Alzheimer’s detection, crucial for timely treatment as new therapies develop.
A Blood Test Accurately Diagnosed Alzheimer's 90% of the Time, Study Finds
A blood test for Alzheimer's disease shows 90% accuracy compared to cognitive tests and CT scans, revolutionizing diagnosis possibilities.
A new Alzheimer's study suggests where you live can affect the odds of a diagnosis
Diagnosis rates for Alzheimer's vary significantly across the U.S., potentially influenced by stigma and access to healthcare.
Blood tests for Alzheimer's may be coming to your doctor's office. Here's what to know
New blood tests for Alzheimer's show promise, but their accuracy varies. Current tests lack widespread use, FDA approval, insurance coverage, and consensus on reliability.
Blood Tests for Alzheimer's May Be Coming to Your Doctor's Office
New blood tests for Alzheimer's are promising but need more evidence for widespread adoption.
A Blood Test for Alzheimer's
AlzPath's blood test for ptau217 offers early Alzheimer’s detection, crucial for timely treatment as new therapies develop.
A Blood Test Accurately Diagnosed Alzheimer's 90% of the Time, Study Finds
A blood test for Alzheimer's disease shows 90% accuracy compared to cognitive tests and CT scans, revolutionizing diagnosis possibilities.
A new Alzheimer's study suggests where you live can affect the odds of a diagnosis
Diagnosis rates for Alzheimer's vary significantly across the U.S., potentially influenced by stigma and access to healthcare.
Blood tests for Alzheimer's may be coming to your doctor's office. Here's what to know
New blood tests for Alzheimer's show promise, but their accuracy varies. Current tests lack widespread use, FDA approval, insurance coverage, and consensus on reliability.
Blood Tests for Alzheimer's May Be Coming to Your Doctor's Office
New blood tests for Alzheimer's are promising but need more evidence for widespread adoption.
A Simple Blood Test Outperformed Doctors in Spotting This Devastating Memory Disease
A blood test can identify Alzheimer's disease more accurately than traditional methods.
Can One Protein Make a Difference in Preventing Alzheimer's?
The discovery of a genetic resilience to early onset Alzheimer's, linked to the protein Reelin, poses new possibilities for Alzheimer's treatments.
Francisco Lopera, Pioneer in Alzheimer's Research, Dies at 73
Dr. Francisco Lopera significantly advanced Alzheimer's research through his work with a large Colombian family, identifying genetic causes and focusing on care for affected patients.
2021: Anti-amyloid antibodies take a bumpy road to the clinic
The initial disease-modifying therapy for Alzheimer's sparked complex reactions rather than unbridled joy.
A Simple Blood Test Outperformed Doctors in Spotting This Devastating Memory Disease
A blood test can identify Alzheimer's disease more accurately than traditional methods.
Can One Protein Make a Difference in Preventing Alzheimer's?
The discovery of a genetic resilience to early onset Alzheimer's, linked to the protein Reelin, poses new possibilities for Alzheimer's treatments.
Francisco Lopera, Pioneer in Alzheimer's Research, Dies at 73
Dr. Francisco Lopera significantly advanced Alzheimer's research through his work with a large Colombian family, identifying genetic causes and focusing on care for affected patients.
2021: Anti-amyloid antibodies take a bumpy road to the clinic
The initial disease-modifying therapy for Alzheimer's sparked complex reactions rather than unbridled joy.
Leonard Riggio, founder of Barnes & Noble, died at 83 after battling Alzheimer's, leaving behind a significant legacy in retail and entrepreneurship.
Leonard Riggio, who forged a bookselling empire at Barnes & Noble, dead at 83
Leonard Riggio revolutionized the publishing industry with Barnes & Noble, fostering a culture of innovation and accessibility before passing away at age 83.
Brooklyn remembers Leonard Riggio, who expanded Barnes & Noble into an empire
Leonard Riggio, influential in transforming Barnes & Noble, passed away at 83, leaving a legacy in bookselling and his community.
Barnes & Noble founder Leonard Riggio dies at 83
Leonard Riggio, founder of Barnes & Noble, died at 83 after battling Alzheimer's, leaving behind a significant legacy in retail and entrepreneurship.
Leonard Riggio, who forged a bookselling empire at Barnes & Noble, dead at 83
Leonard Riggio revolutionized the publishing industry with Barnes & Noble, fostering a culture of innovation and accessibility before passing away at age 83.
Brooklyn remembers Leonard Riggio, who expanded Barnes & Noble into an empire
Leonard Riggio, influential in transforming Barnes & Noble, passed away at 83, leaving a legacy in bookselling and his community.
Gena Rowlands, The Notebook Actress and Film Icon, Dead at 94
Gena Rowlands, acclaimed actress known for iconic films, passed away at 94 after battling Alzheimer's disease.
Gena Rowlands, star of A Woman Under the Influence and Gloria, dies at 94
Gena Rowlands, acclaimed actress and three-time Emmy winner, has passed away at 94, celebrated for her impactful roles and collaborative work with John Cassavetes.
The Notebook star Gena Rowlands dies at 94
Gena Rowlands, iconic actress and long-time collaborator with husband John Cassavetes, leaves a legacy of groundbreaking female-centric films.
Gena Rowlands, star of 'The Notebook,' dead at 94
Gena Rowlands, celebrated actress and independent film pioneer, passed away at age 94, leaving a profound legacy in cinema.
Gena Rowlands, The Notebook Actress and Film Icon, Dead at 94
Gena Rowlands, acclaimed actress known for iconic films, passed away at 94 after battling Alzheimer's disease.
Gena Rowlands, star of A Woman Under the Influence and Gloria, dies at 94
Gena Rowlands, acclaimed actress and three-time Emmy winner, has passed away at 94, celebrated for her impactful roles and collaborative work with John Cassavetes.
The Notebook star Gena Rowlands dies at 94
Gena Rowlands, iconic actress and long-time collaborator with husband John Cassavetes, leaves a legacy of groundbreaking female-centric films.
Gena Rowlands, star of 'The Notebook,' dead at 94
Gena Rowlands, celebrated actress and independent film pioneer, passed away at age 94, leaving a profound legacy in cinema.